Pfizer (PFE) Cash & Equivalents (2009 - 2026)
Pfizer's Cash & Equivalents came in at $976 million for Q2 2026, down 40.4% from $1.64 billion a year earlier and down 42.7% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer's Cash & Equivalents was $1.14 billion, up 9.5% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -8.6% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $1.04 billion in FY2024 (-63.4%), $2.85 billion in FY2023 (+585.8%), $416 million in FY2022 (-78.6%) and $1.94 billion in FY2021 (+8.8%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q1 2024.
- Year-over-year, Cash & Equivalents increased in five of the last seven quarters, with growth averaging 14.6%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2023 (growth of 585.8%), and the weakest in Q4 2022 (a decline of 78.6%).
- Business Quant data shows PFE's Cash & Equivalents at $1.7 billion (Q1 2026), $1.14 billion (Q4 2025) and $1.34 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 6.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 976.00 Mn |
| Mar 29, 2026 | 1.70 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 28, 2025 | 1.34 Bn |
| Jun 29, 2025 | 1.64 Bn |
| Mar 30, 2025 | 1.43 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 29, 2024 | 1.09 Bn |
| Jun 30, 2024 | 1.05 Bn |
| Mar 31, 2024 | 719.00 Mn |
| Dec 31, 2023 | 2.85 Bn |
| Oct 1, 2023 | 3.15 Bn |
| Jul 2, 2023 | 2.63 Bn |
| Apr 2, 2023 | 2.17 Bn |
| Dec 31, 2022 | 416.00 Mn |
| Oct 2, 2022 | 1.30 Bn |
| Jul 3, 2022 | 1.78 Bn |
| Apr 3, 2022 | 2.47 Bn |
| Dec 31, 2021 | 1.94 Bn |
| Oct 3, 2021 | 1.97 Bn |
API Access
Pfizer Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();